Kestra Advisory Services’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-506
| Closed | -$6.7K | – | 2798 |
|
2024
Q4 | $6.7K | Hold |
506
| – | – | ﹤0.01% | 2629 |
|
2024
Q3 | $5.05K | Hold |
506
| – | – | ﹤0.01% | 2532 |
|
2024
Q2 | $11.3K | Hold |
506
| – | – | ﹤0.01% | 2597 |
|
2024
Q1 | $29.7K | Hold |
506
| – | – | ﹤0.01% | 2419 |
|
2023
Q4 | $11.2K | Hold |
506
| – | – | ﹤0.01% | 2257 |
|
2023
Q3 | $10.9K | Hold |
506
| – | – | ﹤0.01% | 2096 |
|
2023
Q2 | $34.2K | Hold |
506
| – | – | ﹤0.01% | 2060 |
|
2023
Q1 | $236K | Sell |
506
-13
| -3% | -$6.06K | ﹤0.01% | 1723 |
|
2022
Q4 | $208K | Buy |
519
+12
| +2% | +$4.81K | ﹤0.01% | 2001 |
|
2022
Q3 | $165K | Buy |
507
+1
| +0.2% | +$325 | ﹤0.01% | 1908 |
|
2022
Q2 | $134K | Sell |
506
-32
| -6% | -$8.47K | ﹤0.01% | 1951 |
|
2022
Q1 | $162K | Buy |
538
+60
| +13% | +$18.1K | ﹤0.01% | 1890 |
|
2021
Q4 | $168K | Sell |
478
-120
| -20% | -$42.2K | ﹤0.01% | 1900 |
|
2021
Q3 | $153K | Sell |
598
-260
| -30% | -$66.5K | ﹤0.01% | 2015 |
|
2021
Q2 | $571K | Buy |
858
+409
| +91% | +$272K | 0.01% | 1221 |
|
2021
Q1 | $389K | Sell |
449
-15
| -3% | -$13K | ﹤0.01% | 1314 |
|
2020
Q4 | $440K | Buy |
+464
| New | +$440K | 0.01% | 1272 |
|